_id
691305bdccc777a4e85d7ab4
Ticker
JBIO
Name
Jade Biosciences, Inc.
Exchange
NASDAQ
Address
Building 23, Waltham, MA, United States, 02453
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://jadebiosciences.com
Description
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. It also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Last Close
15.43
Volume
236226
Current Price
13.3
Change
-1.27
Last Updated
2026-01-04T15:37:31.279Z
Image
data:image/webp;base64,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
Ipo Date
2021-06-30T00:00:00.000Z
Market Cap
280129952
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.5393333333333333
Sentiment Sources
3
Rating
5
Target Price
-
Strong Buy
3
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
12000
Gross Profit
-12000
Operating Expenses
27389000
Operating Income
-27401000
Interest Expense
-
Pretax Income
-25175000
Net Income
-25175000
Eps
-0.6359814320200016
Dividends Per Share
-
Shares Outstanding
32235900
Income Tax Expense
-
EBITDA
-25163000
Operating Margin
-
Total Other Income Expense Net
2226000
Cash
50106000
Short Term Investments
148799000
Receivables
-
Inventories
-
Total Current Assets
201360000
Property Plant Equipment
916000
Total Assets
202450000
Payables
1350000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
23104000
Equity
179346000
Bs_currency_symbol
USD
Depreciation
12000
Change In Working Capital
-1065000
Cash From Operations
-22124000
Capital Expenditures
57000
Cash From Investing
-148708000
Cash From Financing
0
Net Change In Cash
-170836000
Cf_currency_symbol
USD
PE
-
PB
2.9355196307695737
ROE
-14.037112620298196
ROA
-12.435169177574709
FCF
-22181000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
12000
Quarters > 0 > income Statement > gross Profit
-12000
Quarters > 0 > income Statement > operating Expenses
27389000
Quarters > 0 > income Statement > operating Income
-27401000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-25175000
Quarters > 0 > income Statement > net Income
-25175000
Quarters > 0 > income Statement > eps
-0.6359814320200016
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
39584489
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-25163000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2226000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
50106000
Quarters > 0 > balance Sheet > short Term Investments
148799000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
201360000
Quarters > 0 > balance Sheet > property Plant Equipment
916000
Quarters > 0 > balance Sheet > total Assets
202450000
Quarters > 0 > balance Sheet > payables
1350000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
23104000
Quarters > 0 > balance Sheet > equity
179346000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-25175000
Quarters > 0 > cash Flow > depreciation
12000
Quarters > 0 > cash Flow > change In Working Capital
-1065000
Quarters > 0 > cash Flow > cash From Operations
-22124000
Quarters > 0 > cash Flow > capital Expenditures
57000
Quarters > 0 > cash Flow > cash From Investing
-148708000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-170836000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6359814320200016
Quarters > 0 > ratios > PB
2.9355196307695737
Quarters > 0 > ratios > ROE
-14.037112620298196
Quarters > 0 > ratios > ROA
-12.435169177574709
Quarters > 0 > ratios > FCF
-22181000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
1000
Quarters > 1 > income Statement > gross Profit
-1000
Quarters > 1 > income Statement > operating Expenses
27778000
Quarters > 1 > income Statement > operating Income
-27778000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-32134000
Quarters > 1 > income Statement > net Income
-32134000
Quarters > 1 > income Statement > eps
-1.1302388738439708
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
28431158
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-32133000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-4356000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
220942000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
222984000
Quarters > 1 > balance Sheet > property Plant Equipment
924000
Quarters > 1 > balance Sheet > total Assets
223968000
Quarters > 1 > balance Sheet > payables
7586000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
22412000
Quarters > 1 > balance Sheet > equity
201556000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-32134000
Quarters > 1 > cash Flow > depreciation
1000
Quarters > 1 > cash Flow > change In Working Capital
4233000
Quarters > 1 > cash Flow > cash From Operations
-36535000
Quarters > 1 > cash Flow > capital Expenditures
136000
Quarters > 1 > cash Flow > cash From Investing
-12986000
Quarters > 1 > cash Flow > cash From Financing
190608000
Quarters > 1 > cash Flow > net Change In Cash
176722000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.1302388738439708
Quarters > 1 > ratios > PB
1.87607613467225
Quarters > 1 > ratios > ROE
-15.942963742086565
Quarters > 1 > ratios > ROA
-14.347585369338479
Quarters > 1 > ratios > FCF
-36671000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
4000
Quarters > 2 > income Statement > gross Profit
-4000
Quarters > 2 > income Statement > operating Expenses
3383000
Quarters > 2 > income Statement > operating Income
-3387000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2518000
Quarters > 2 > income Statement > net Income
-2518000
Quarters > 2 > income Statement > eps
-3.0405376849167354
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
828143
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2514000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
869000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
44220000
Quarters > 2 > balance Sheet > short Term Investments
31990000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
77373000
Quarters > 2 > balance Sheet > property Plant Equipment
160000
Quarters > 2 > balance Sheet > total Assets
77533000
Quarters > 2 > balance Sheet > payables
69000
Quarters > 2 > balance Sheet > short Term Debt
312000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2487000
Quarters > 2 > balance Sheet > equity
75046000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-38169000
Quarters > 2 > cash Flow > depreciation
4000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-3.0405376849167354
Quarters > 2 > ratios > PB
0.14676734136396344
Quarters > 2 > ratios > ROE
-3.3552754310689443
Quarters > 2 > ratios > ROA
-3.247649388002528
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
8000
Quarters > 3 > income Statement > gross Profit
-8000
Quarters > 3 > income Statement > operating Expenses
6395000
Quarters > 3 > income Statement > operating Income
-6403000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-5375000
Quarters > 3 > income Statement > net Income
-5430000
Quarters > 3 > income Statement > eps
-6.5568386136210774
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
828143
Quarters > 3 > income Statement > income Tax Expense
55000
Quarters > 3 > income Statement > EBITDA
-5367000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
1028000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
33751000
Quarters > 3 > balance Sheet > short Term Investments
44872000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
80117000
Quarters > 3 > balance Sheet > property Plant Equipment
215000
Quarters > 3 > balance Sheet > total Assets
80332000
Quarters > 3 > balance Sheet > payables
224000
Quarters > 3 > balance Sheet > short Term Debt
417000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3898000
Quarters > 3 > balance Sheet > equity
76434000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-5430000
Quarters > 3 > cash Flow > depreciation
8000
Quarters > 3 > cash Flow > change In Working Capital
-6568220
Quarters > 3 > cash Flow > cash From Operations
-11047000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
13129000
Quarters > 3 > cash Flow > cash From Financing
554000
Quarters > 3 > cash Flow > net Change In Cash
2636000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-6.5568386136210774
Quarters > 3 > ratios > PB
0.14410212601721747
Quarters > 3 > ratios > ROE
-7.104168302064526
Quarters > 3 > ratios > ROA
-6.759448289598168
Quarters > 3 > ratios > FCF
-11047000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
282000
Annuals > 0 > income Statement > gross Profit
-282000
Annuals > 0 > income Statement > operating Expenses
74314000
Annuals > 0 > income Statement > operating Income
-74596000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-69573000
Annuals > 0 > income Statement > net Income
-69628000
Annuals > 0 > income Statement > eps
-85.26218599764398
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
816634
Annuals > 0 > income Statement > income Tax Expense
55000
Annuals > 0 > income Statement > EBITDA
-69291000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
5023000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
33751000
Annuals > 0 > balance Sheet > short Term Investments
44872000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
80117000
Annuals > 0 > balance Sheet > property Plant Equipment
215000
Annuals > 0 > balance Sheet > total Assets
80332000
Annuals > 0 > balance Sheet > payables
224000
Annuals > 0 > balance Sheet > short Term Debt
417000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3898000
Annuals > 0 > balance Sheet > equity
76434000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-69628000
Annuals > 0 > cash Flow > depreciation
282000
Annuals > 0 > cash Flow > change In Working Capital
-11169000
Annuals > 0 > cash Flow > cash From Operations
-71196000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
56029000
Annuals > 0 > cash Flow > cash From Financing
25427000
Annuals > 0 > cash Flow > net Change In Cash
10260000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-85.26218599764398
Annuals > 0 > ratios > PB
0.15128787502943716
Annuals > 0 > ratios > ROE
-91.0955857340974
Annuals > 0 > ratios > ROA
-86.67529751531146
Annuals > 0 > ratios > FCF
-71196000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
42
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
96000
Annuals > 1 > income Statement > gross Profit
-96000
Annuals > 1 > income Statement > operating Expenses
81313000
Annuals > 1 > income Statement > operating Income
-81409000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-75465000
Annuals > 1 > income Statement > net Income
-75521000
Annuals > 1 > income Statement > eps
-100.3825438769054
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
752332
Annuals > 1 > income Statement > income Tax Expense
56000
Annuals > 1 > income Statement > EBITDA
-75369000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
5944000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
23491000
Annuals > 1 > balance Sheet > short Term Investments
98948000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
124232000
Annuals > 1 > balance Sheet > property Plant Equipment
902000
Annuals > 1 > balance Sheet > total Assets
127418000
Annuals > 1 > balance Sheet > payables
2396000
Annuals > 1 > balance Sheet > short Term Debt
420000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
17962000
Annuals > 1 > balance Sheet > equity
109456000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-75521000
Annuals > 1 > cash Flow > depreciation
96000
Annuals > 1 > cash Flow > change In Working Capital
9798000
Annuals > 1 > cash Flow > cash From Operations
-56778000
Annuals > 1 > cash Flow > capital Expenditures
142000
Annuals > 1 > cash Flow > cash From Investing
11876000
Annuals > 1 > cash Flow > cash From Financing
45996000
Annuals > 1 > cash Flow > net Change In Cash
1094000
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-100.3825438769054
Annuals > 1 > ratios > PB
0.09732697266481509
Annuals > 1 > ratios > ROE
-68.99667446279784
Annuals > 1 > ratios > ROA
-59.27027578521088
Annuals > 1 > ratios > FCF
-56920000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
41
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
68000
Annuals > 2 > income Statement > gross Profit
-68000
Annuals > 2 > income Statement > operating Expenses
53169000
Annuals > 2 > income Statement > operating Income
-53237000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-51486000
Annuals > 2 > income Statement > net Income
-51511000
Annuals > 2 > income Statement > eps
-73.67112794299787
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
699202
Annuals > 2 > income Statement > income Tax Expense
25000
Annuals > 2 > income Statement > EBITDA
-51418000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1751000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
22397000
Annuals > 2 > balance Sheet > short Term Investments
106823000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
131496000
Annuals > 2 > balance Sheet > property Plant Equipment
1245000
Annuals > 2 > balance Sheet > total Assets
135301000
Annuals > 2 > balance Sheet > payables
2575000
Annuals > 2 > balance Sheet > short Term Debt
385000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
8558000
Annuals > 2 > balance Sheet > equity
126743000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-51511000
Annuals > 2 > cash Flow > depreciation
68000
Annuals > 2 > cash Flow > change In Working Capital
7755000
Annuals > 2 > cash Flow > cash From Operations
-39122000
Annuals > 2 > cash Flow > capital Expenditures
195000
Annuals > 2 > cash Flow > cash From Investing
6926000
Annuals > 2 > cash Flow > cash From Financing
396000
Annuals > 2 > cash Flow > net Change In Cash
-31800000
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-73.67112794299787
Annuals > 2 > ratios > PB
0.07811634820068959
Annuals > 2 > ratios > ROE
-40.64208674246309
Annuals > 2 > ratios > ROA
-38.07141114995455
Annuals > 2 > ratios > FCF
-39317000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
41
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
15000
Annuals > 3 > income Statement > gross Profit
-15000
Annuals > 3 > income Statement > operating Expenses
23007000
Annuals > 3 > income Statement > operating Income
-23022000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-22960000
Annuals > 3 > income Statement > net Income
-22963000
Annuals > 3 > income Statement > eps
-32.92474323919368
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
697439
Annuals > 3 > income Statement > income Tax Expense
3000
Annuals > 3 > income Statement > EBITDA
-22945000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
62000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
54197000
Annuals > 3 > balance Sheet > short Term Investments
113178000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
174333000
Annuals > 3 > balance Sheet > property Plant Equipment
728000
Annuals > 3 > balance Sheet > total Assets
175363000
Annuals > 3 > balance Sheet > payables
1208000
Annuals > 3 > balance Sheet > short Term Debt
192000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2945000
Annuals > 3 > balance Sheet > equity
172418000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-22963000
Annuals > 3 > cash Flow > depreciation
15000
Annuals > 3 > cash Flow > change In Working Capital
-6510000
Annuals > 3 > cash Flow > cash From Operations
-27399000
Annuals > 3 > cash Flow > capital Expenditures
181000
Annuals > 3 > cash Flow > cash From Investing
-113434000
Annuals > 3 > cash Flow > cash From Financing
190457000
Annuals > 3 > cash Flow > net Change In Cash
49624000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-32.92474323919368
Annuals > 3 > ratios > PB
0.05727787261190827
Annuals > 3 > ratios > ROE
-13.318215035553132
Annuals > 3 > ratios > ROA
-13.094552442647537
Annuals > 3 > ratios > FCF
-27580000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
42
Valuation > metrics > PE
-0.6359814320200016
Valuation > metrics > PB
2.9355196307695737
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-14.037112620298196
Profitability > metrics > ROA
-12.50248311481923
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.1288236146889253
Risk > metrics > Interest Coverage
-2283.4166666666665
Risk > final Score
-9074
Risk > verdict
High
Liquidity > metrics > Current Ratio
149.15555555555557
Liquidity > metrics > Quick Ratio
149.15555555555557
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-111052
Prev Risks > 1
-3327
Prev Risks > 2
-3141
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:04:04.384Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.49
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-12
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.48
Earnings History > 1 > eps Estimate
-0.67
Earnings History > 1 > eps Difference
0.19
Earnings History > 1 > surprise Percent
28.3582
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-13
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.86
Earnings History > 2 > eps Estimate
-0.48
Earnings History > 2 > eps Difference
-0.38
Earnings History > 2 > surprise Percent
-79.1667
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-14
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-12.1
Earnings History > 3 > eps Estimate
-2.05
Earnings History > 3 > eps Difference
-10.05
Earnings History > 3 > surprise Percent
-490.2439
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-6.61
Earnings History > 4 > eps Estimate
-0.4025
Earnings History > 4 > eps Difference
-6.2075
Earnings History > 4 > surprise Percent
-1542.236
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-11
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-19.6
Earnings History > 5 > eps Estimate
-0.5808
Earnings History > 5 > eps Difference
-19.0192
Earnings History > 5 > surprise Percent
-3274.6556
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-12
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-30.1
Earnings History > 6 > eps Estimate
-0.85
Earnings History > 6 > eps Difference
-29.25
Earnings History > 6 > surprise Percent
-3441.1765
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-13
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.83
Earnings History > 7 > eps Estimate
-0.76
Earnings History > 7 > eps Difference
-0.07
Earnings History > 7 > surprise Percent
-9.2105
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-25
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-25.9
Earnings History > 8 > eps Estimate
-0.74
Earnings History > 8 > eps Difference
-25.16
Earnings History > 8 > surprise Percent
-3400
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-13
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.71
Earnings History > 9 > eps Estimate
-0.69
Earnings History > 9 > eps Difference
-0.02
Earnings History > 9 > surprise Percent
-2.8986
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-14
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.76
Earnings History > 10 > eps Estimate
-0.7
Earnings History > 10 > eps Difference
-0.06
Earnings History > 10 > surprise Percent
-8.5714
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-16
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.67
Earnings History > 11 > eps Estimate
-0.57
Earnings History > 11 > eps Difference
-0.1
Earnings History > 11 > surprise Percent
-17.5439
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-29
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-21.35
Earnings History > 12 > eps Estimate
-0.61
Earnings History > 12 > eps Difference
-20.74
Earnings History > 12 > surprise Percent
-3400
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-14
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.56
Earnings History > 13 > eps Estimate
-0.5
Earnings History > 13 > eps Difference
-0.06
Earnings History > 13 > surprise Percent
-12
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-17
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-17.15
Earnings History > 14 > eps Estimate
-0.49
Earnings History > 14 > eps Difference
-16.66
Earnings History > 14 > surprise Percent
-3400
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-16
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-15.75
Earnings History > 15 > eps Estimate
-0.45
Earnings History > 15 > eps Difference
-15.3
Earnings History > 15 > surprise Percent
-3400
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-30
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-11.9
Earnings History > 16 > eps Estimate
-0.33
Earnings History > 16 > eps Difference
-11.57
Earnings History > 16 > surprise Percent
-3506.0606
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-15
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-9.1
Earnings History > 17 > eps Estimate
-0.26
Earnings History > 17 > eps Difference
-8.84
Earnings History > 17 > surprise Percent
-3400
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-16
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-833
Earnings History > 18 > eps Estimate
-23.8
Earnings History > 18 > eps Difference
-809.2
Earnings History > 18 > surprise Percent
-3400
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-06
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-12.77
Earnings History > 19 > eps Estimate
-0.62
Earnings History > 19 > eps Difference
-12.15
Earnings History > 19 > surprise Percent
-1959.6774
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. It also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AH.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue Finviz
Read more →H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue Insider Monkey
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
$
Analyst Picks
Strong Buy
3
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Jade Biosciences, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.49
Date
2025-09-30
EPS Actual
-0.48
EPS Estimate
-0.67
EPS Difference
0.19
Surprise Percent
28.3582%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.